Aptinyx Inc. (APTX): Price and Financial Metrics
Aptinyx Inc. (APTX)
Today's Latest Price: $3.14 USD
Updated Sep 25 4:00pm
Add APTX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 233 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
APTX Stock Summary
- Aptinyx Inc's stock had its IPO on June 21, 2018, making it an older stock than just 5.42% of US equities in our set.
- For APTX, its debt to operating expenses ratio is greater than that reported by merely 0.34% of US equities we're observing.
- APTX's price/sales ratio is 46.64; that's higher than the P/S ratio of 95.67% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Aptinyx Inc are FPRX, RGNX, BLUE, AGIO, and CLLS.
- APTX's SEC filings can be seen here. And to visit Aptinyx Inc's official web site, go to www.aptinyx.com.
APTX Stock Price Chart Technical Analysis Charts
APTX Price/Volume Stats
| Current price | $3.14 | 52-week high | $5.28 |
| Prev. close | $3.11 | 52-week low | $1.60 |
| Day low | $3.05 | Volume | 118,184 |
| Day high | $3.31 | Avg. volume | 315,356 |
| 50-day MA | $3.68 | Dividend yield | N/A |
| 200-day MA | $3.52 | Market Cap | 147.46M |
Aptinyx Inc. (APTX) Company Bio
Aptinyx Inc. develops therapeutics for neurological disorders. The company is focused on the development of drugs that interact with the NMDA receptor, and the company says it will use the funds to advance drugs for chronic pain, post-traumatic stress disorder (PTSD) and cognitive impairment in Parkinson’s disease. The company was founded in 2015 and is based in Evantson, Illinois.
Loading social stream, please wait...